Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-Year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages 851-857

  Leirisalo Repo, Marjatta ^a,b   Kautiainen, Hannu ^c,d   Laasonen, Leena ^a   Korpela, Markku ^e   Kauppi, Markku J ^f,g   Kaipiainen Seppänen, Oili ^h   Riitta Luosujärvi, Reijo Luukkainen ^a,h,i   Karjalainen, Anna ^j   Blåfield, Harri ^k   Toini Uutela, Kirsti Ilva ^l,m   Julkunen, Heikki A ^a   Paimela, Leena ^c   Puolakka, Kari ⁿ   Moilanen, Eeva ^o   Hannonen, Pekka J ^d   Möttönen, Timo ^p,q  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Orton Hospital   (Finland)

^d JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^g PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

ⁱ SATAKUNTA CENTRAL HOSPITAL   (Finland)

^j OULU UNIVERSITY HOSPITAL   (Finland)

^k SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^l LAPLAND CENTRAL HOSPITAL   (Finland)

^m Hameenlinna Central Hospital   (Finland)

ⁿ Lappeenranta Central Hospital   (Finland)

^o UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^p TURKU UNIVERSITY HOSPITAL   (Finland)

^q UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADD ON THERAPY; ADULT; AGRANULOCYTOSIS; AMERICAN COLLEGE OF RHEUMATOLOGY CRITERIA; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL ARTHRITIS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DAS28; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG FATALITY; DRUG WITHDRAWAL; EARLY INTERVENTION; FEMALE; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRANSAMINASEMIA; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVARY CYST; PATIENT COMPLIANCE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHARP VAN DER HEIJDE SCORE; SKIN DISEASE; TREATMENT DURATION; UROGENITAL TRACT DISEASE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; HYDROXYCHLOROQUINE; INDUCTION CHEMOTHERAPY; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; SULFASALAZINE; TREATMENT OUTCOME;

EID: 84877631290     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201365     Document Type: Article

References (32)

1. Möttönen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353:1568-73. (Pubitemid 29219206)
2. Combe B. Progression in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009;23:59-69.
3. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15. (Pubitemid 11022943)
4. Mäkinen H, Kautiainen H, Hannonen P, et al. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. J Rheumatol 2007;34:316-21.
5. Schoels M, Knevel R, Aletaha D, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 2010;69:638- 43.
6. Smolen JS, Aletaha D, Biljsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:361-7.
7. Prevoo ML, van' t Hof MA, Kuper HH, et al. Modifi ed disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Ann Rheum Dis 1995;38:44-8.
8. Mäkinen H, Hannonen P, Sokka T. Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission. Clin Exp Rheumatol 2006;24(Suppl 43):S22-8. (Pubitemid 44696864)
9. Puolakka K, Kautiainen H, Möttönen T, et al. Early suppression of disease activity is essential for maintenance of working capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36-41. (Pubitemid 40129230)
10. Puolakka K, Kautiainen H, Pekurinen M, et al. Monetary value of lost productivity over five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients ' sickness absence and gross income: experience from the FIN-RACo Trial. Ann Rheum Dis 2006;65 :899-904.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
12. Felson DT, Andersson JJ, Lange ML, et al. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 1998;41:1564-70. (Pubitemid 28459914)
13. van der Heijde DM, van Leeuwen MA, van Riel PL, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
14. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977;18:481 -91.
15. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18. (Pubitemid 27351112)
16. Calgüneri M, Pay S, Cali?kaner Z, et al. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheumatol 1999; 17:699-704.
17. Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis. A randomized trial. Ann Intern Med 2007;146:406-15. (Pubitemid 351650575)
18. Choy EHS, Smith CM, Farewell V, et al. Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis 2008;67:656-63. (Pubitemid 351571930)
19. van Tuyl LHD, Lems WF, Voskuyl AE, et al. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial. Ann Rheum Dis 2008;67:1574-7.
20. O'Dell JR, Leff R, Paulsen G, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:1164-70. (Pubitemid 34525821)
21. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9. (Pubitemid 38942816)
22. Verstrappen SMM, Jacobs JWG, van der Veen MJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer assisted management in early rheumatoid arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9. (Pubitemid 350032650)
23. Hetland ML, Stengaard-Pedersen K, Junker P, et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008;67:815-22. (Pubitemid 351829382)
24. St Clair EW, van der Heijde DMFM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum 2004;50:3432-43. (Pubitemid 39488667)
25. Quinn MA, Conaghan PG, ÓConnor PJ, et al . Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal. Results form a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35. (Pubitemid 40129229)
26. Emery P, Breedveld FC, Hall S, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008;372:375-82.
27. Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37. (Pubitemid 43122183)
28. Soubrier M, Puéchal X, Sibilia J, et al. Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. Rheumatology 2009;48:1429-34.
29. Breedveld FC, Emery P, Keystone E, et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004;63:149-55. (Pubitemid 38122133)
30. van der Heijde D, Klareskog L, Rodriguez-Valverde V, et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis. Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006;54:1063-74. (Pubitemid 43672919)
31. Choy EH, Smith C, Doré CJ, et al. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology 2005;44:1414-21. (Pubitemid 41631866)
32. Leombruno JP, Einarson TR, Keystone EC. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis 2009;68:1136-45.